About
Neil Kumar, Ph.D., is the founder and CEO of BridgeBio Pharma, a biotechnology company focused on medicines for genetic diseases. Before founding BridgeBio in 2015, he was a principal at Third Rock Ventures and previously an associate principal at McKinsey & Company. Public bios also note that he launched GondolaBio in 2024 and serves on the boards of BIO and Global Genes.
Areas of interest
biotechrare diseasegenetic medicinedrug developmentlife sciencespersonalized medicine